Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1061282

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1061282

Global Restless Legs Syndrome Market Insights and Forecast to 2028

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.

Market Analysis and Insights: Global Restless Legs Syndrome Market

The global Restless Legs Syndrome market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Pharmacological Therapy accounting for % of the Restless Legs Syndrome global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Below 35 YearsOld segment is altered to an % CAGR throughout this forecast period.

China Restless Legs Syndrome market size is valued at US$ million in 2021, while the North America and Europe Restless Legs Syndrome are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Restless Legs Syndrome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Restless Legs Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Restless Legs Syndrome market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Restless Legs Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Restless Legs Syndrome market.

Global Restless Legs Syndrome Scope and Market Size

Restless Legs Syndrome market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Restless Legs Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Pharmacological Therapy
  • Non-Pharmacological Therapy

Segment by Application

  • Below 35 YearsOld
  • 35-50 Years Old
  • Above50 YearsOld

By Company

  • GlaxoSmithKline plc.
  • Ligand Pharmaceuticals Incorporated
  • axxonis Pharma AG
  • Kyowa Hakko Kirin
  • Jazz Pharmaceuticals
  • Omeros Corporation
  • Manhattan Pharmaceuticals
  • Boehringer Ingelheim GmbH
  • UCB SA

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Pharmacological Therapy
    • 1.2.3 Non-Pharmacological Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Restless Legs Syndrome Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Below 35 YearsOld
    • 1.3.3 35-50 Years Old
    • 1.3.4 Above50 YearsOld
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Restless Legs Syndrome Market Perspective (2017-2028)
  • 2.2 Restless Legs Syndrome Growth Trends by Region
    • 2.2.1 Restless Legs Syndrome Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Restless Legs Syndrome Historic Market Size by Region (2017-2022)
    • 2.2.3 Restless Legs Syndrome Forecasted Market Size by Region (2023-2028)
  • 2.3 Restless Legs Syndrome Market Dynamics
    • 2.3.1 Restless Legs Syndrome Industry Trends
    • 2.3.2 Restless Legs Syndrome Market Drivers
    • 2.3.3 Restless Legs Syndrome Market Challenges
    • 2.3.4 Restless Legs Syndrome Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Restless Legs Syndrome Players by Revenue
    • 3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2017-2022)
    • 3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2017-2022)
  • 3.2 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Restless Legs Syndrome Revenue
  • 3.4 Global Restless Legs Syndrome Market Concentration Ratio
    • 3.4.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2021
  • 3.5 Restless Legs Syndrome Key Players Head office and Area Served
  • 3.6 Key Players Restless Legs Syndrome Product Solution and Service
  • 3.7 Date of Enter into Restless Legs Syndrome Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Restless Legs Syndrome Breakdown Data by Type

  • 4.1 Global Restless Legs Syndrome Historic Market Size by Type (2017-2022)
  • 4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2023-2028)

5 Restless Legs Syndrome Breakdown Data by Application

  • 5.1 Global Restless Legs Syndrome Historic Market Size by Application (2017-2022)
  • 5.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Restless Legs Syndrome Market Size (2017-2028)
  • 6.2 North America Restless Legs Syndrome Market Size by Type
    • 6.2.1 North America Restless Legs Syndrome Market Size by Type (2017-2022)
    • 6.2.2 North America Restless Legs Syndrome Market Size by Type (2023-2028)
    • 6.2.3 North America Restless Legs Syndrome Market Share by Type (2017-2028)
  • 6.3 North America Restless Legs Syndrome Market Size by Application
    • 6.3.1 North America Restless Legs Syndrome Market Size by Application (2017-2022)
    • 6.3.2 North America Restless Legs Syndrome Market Size by Application (2023-2028)
    • 6.3.3 North America Restless Legs Syndrome Market Share by Application (2017-2028)
  • 6.4 North America Restless Legs Syndrome Market Size by Country
    • 6.4.1 North America Restless Legs Syndrome Market Size by Country (2017-2022)
    • 6.4.2 North America Restless Legs Syndrome Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Restless Legs Syndrome Market Size (2017-2028)
  • 7.2 Europe Restless Legs Syndrome Market Size by Type
    • 7.2.1 Europe Restless Legs Syndrome Market Size by Type (2017-2022)
    • 7.2.2 Europe Restless Legs Syndrome Market Size by Type (2023-2028)
    • 7.2.3 Europe Restless Legs Syndrome Market Share by Type (2017-2028)
  • 7.3 Europe Restless Legs Syndrome Market Size by Application
    • 7.3.1 Europe Restless Legs Syndrome Market Size by Application (2017-2022)
    • 7.3.2 Europe Restless Legs Syndrome Market Size by Application (2023-2028)
    • 7.3.3 Europe Restless Legs Syndrome Market Share by Application (2017-2028)
  • 7.4 Europe Restless Legs Syndrome Market Size by Country
    • 7.4.1 Europe Restless Legs Syndrome Market Size by Country (2017-2022)
    • 7.4.2 Europe Restless Legs Syndrome Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Restless Legs Syndrome Market Size (2017-2028)
  • 8.2 Asia-Pacific Restless Legs Syndrome Market Size by Type
    • 8.2.1 Asia-Pacific Restless Legs Syndrome Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Restless Legs Syndrome Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Restless Legs Syndrome Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Restless Legs Syndrome Market Size by Application
    • 8.3.1 Asia-Pacific Restless Legs Syndrome Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Restless Legs Syndrome Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Restless Legs Syndrome Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Restless Legs Syndrome Market Size by Region
    • 8.4.1 Asia-Pacific Restless Legs Syndrome Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Restless Legs Syndrome Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Restless Legs Syndrome Market Size (2017-2028)
  • 9.2 Latin America Restless Legs Syndrome Market Size by Type
    • 9.2.1 Latin America Restless Legs Syndrome Market Size by Type (2017-2022)
    • 9.2.2 Latin America Restless Legs Syndrome Market Size by Type (2023-2028)
    • 9.2.3 Latin America Restless Legs Syndrome Market Share by Type (2017-2028)
  • 9.3 Latin America Restless Legs Syndrome Market Size by Application
    • 9.3.1 Latin America Restless Legs Syndrome Market Size by Application (2017-2022)
    • 9.3.2 Latin America Restless Legs Syndrome Market Size by Application (2023-2028)
    • 9.3.3 Latin America Restless Legs Syndrome Market Share by Application (2017-2028)
  • 9.4 Latin America Restless Legs Syndrome Market Size by Country
    • 9.4.1 Latin America Restless Legs Syndrome Market Size by Country (2017-2022)
    • 9.4.2 Latin America Restless Legs Syndrome Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Restless Legs Syndrome Market Size (2017-2028)
  • 10.2 Middle East & Africa Restless Legs Syndrome Market Size by Type
    • 10.2.1 Middle East & Africa Restless Legs Syndrome Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Restless Legs Syndrome Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Restless Legs Syndrome Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Restless Legs Syndrome Market Size by Application
    • 10.3.1 Middle East & Africa Restless Legs Syndrome Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Restless Legs Syndrome Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Restless Legs Syndrome Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Restless Legs Syndrome Market Size by Country
    • 10.4.1 Middle East & Africa Restless Legs Syndrome Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Restless Legs Syndrome Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 GlaxoSmithKline plc.
    • 11.1.1 GlaxoSmithKline plc. Company Details
    • 11.1.2 GlaxoSmithKline plc. Business Overview
    • 11.1.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction
    • 11.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.1.5 GlaxoSmithKline plc. Recent Developments
  • 11.2 Ligand Pharmaceuticals Incorporated
    • 11.2.1 Ligand Pharmaceuticals Incorporated Company Details
    • 11.2.2 Ligand Pharmaceuticals Incorporated Business Overview
    • 11.2.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction
    • 11.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.2.5 Ligand Pharmaceuticals Incorporated Recent Developments
  • 11.3 axxonis Pharma AG
    • 11.3.1 axxonis Pharma AG Company Details
    • 11.3.2 axxonis Pharma AG Business Overview
    • 11.3.3 axxonis Pharma AG Restless Legs Syndrome Introduction
    • 11.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.3.5 axxonis Pharma AG Recent Developments
  • 11.4 Kyowa Hakko Kirin
    • 11.4.1 Kyowa Hakko Kirin Company Details
    • 11.4.2 Kyowa Hakko Kirin Business Overview
    • 11.4.3 Kyowa Hakko Kirin Restless Legs Syndrome Introduction
    • 11.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.4.5 Kyowa Hakko Kirin Recent Developments
  • 11.5 Jazz Pharmaceuticals
    • 11.5.1 Jazz Pharmaceuticals Company Details
    • 11.5.2 Jazz Pharmaceuticals Business Overview
    • 11.5.3 Jazz Pharmaceuticals Restless Legs Syndrome Introduction
    • 11.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.5.5 Jazz Pharmaceuticals Recent Developments
  • 11.6 Omeros Corporation
    • 11.6.1 Omeros Corporation Company Details
    • 11.6.2 Omeros Corporation Business Overview
    • 11.6.3 Omeros Corporation Restless Legs Syndrome Introduction
    • 11.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.6.5 Omeros Corporation Recent Developments
  • 11.7 Manhattan Pharmaceuticals
    • 11.7.1 Manhattan Pharmaceuticals Company Details
    • 11.7.2 Manhattan Pharmaceuticals Business Overview
    • 11.7.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction
    • 11.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.7.5 Manhattan Pharmaceuticals Recent Developments
  • 11.8 Boehringer Ingelheim GmbH
    • 11.8.1 Boehringer Ingelheim GmbH Company Details
    • 11.8.2 Boehringer Ingelheim GmbH Business Overview
    • 11.8.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction
    • 11.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.8.5 Boehringer Ingelheim GmbH Recent Developments
  • 11.9 UCB SA
    • 11.9.1 UCB SA Company Details
    • 11.9.2 UCB SA Business Overview
    • 11.9.3 UCB SA Restless Legs Syndrome Introduction
    • 11.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2017-2022)
    • 11.9.5 UCB SA Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Pharmacological Therapy
  • Table 3. Key Players of Non-Pharmacological Therapy
  • Table 4. Global Restless Legs Syndrome Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Restless Legs Syndrome Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Restless Legs Syndrome Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Restless Legs Syndrome Market Share by Region (2017-2022)
  • Table 8. Global Restless Legs Syndrome Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Restless Legs Syndrome Market Share by Region (2023-2028)
  • Table 10. Restless Legs Syndrome Market Trends
  • Table 11. Restless Legs Syndrome Market Drivers
  • Table 12. Restless Legs Syndrome Market Challenges
  • Table 13. Restless Legs Syndrome Market Restraints
  • Table 14. Global Restless Legs Syndrome Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Restless Legs Syndrome Revenue Share by Players (2017-2022)
  • Table 16. Global Top Restless Legs Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2021)
  • Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Restless Legs Syndrome Product Solution and Service
  • Table 21. Date of Enter into Restless Legs Syndrome Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2017-2022)
  • Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2023-2028)
  • Table 27. Global Restless Legs Syndrome Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Restless Legs Syndrome Revenue Share by Application (2017-2022)
  • Table 29. Global Restless Legs Syndrome Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Restless Legs Syndrome Revenue Share by Application (2023-2028)
  • Table 31. North America Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Restless Legs Syndrome Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Restless Legs Syndrome Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Restless Legs Syndrome Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Restless Legs Syndrome Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Restless Legs Syndrome Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Restless Legs Syndrome Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Restless Legs Syndrome Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Restless Legs Syndrome Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Restless Legs Syndrome Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Restless Legs Syndrome Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Restless Legs Syndrome Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Restless Legs Syndrome Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Restless Legs Syndrome Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Restless Legs Syndrome Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Restless Legs Syndrome Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Restless Legs Syndrome Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Restless Legs Syndrome Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Restless Legs Syndrome Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Restless Legs Syndrome Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Restless Legs Syndrome Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. GlaxoSmithKline plc. Company Details
  • Table 62. GlaxoSmithKline plc. Business Overview
  • Table 63. GlaxoSmithKline plc. Restless Legs Syndrome Product
  • Table 64. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 65. GlaxoSmithKline plc. Recent Developments
  • Table 66. Ligand Pharmaceuticals Incorporated Company Details
  • Table 67. Ligand Pharmaceuticals Incorporated Business Overview
  • Table 68. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product
  • Table 69. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 70. Ligand Pharmaceuticals Incorporated Recent Developments
  • Table 71. axxonis Pharma AG Company Details
  • Table 72. axxonis Pharma AG Business Overview
  • Table 73. axxonis Pharma AG Restless Legs Syndrome Product
  • Table 74. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 75. axxonis Pharma AG Recent Developments
  • Table 76. Kyowa Hakko Kirin Company Details
  • Table 77. Kyowa Hakko Kirin Business Overview
  • Table 78. Kyowa Hakko Kirin Restless Legs Syndrome Product
  • Table 79. Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 80. Kyowa Hakko Kirin Recent Developments
  • Table 81. Jazz Pharmaceuticals Company Details
  • Table 82. Jazz Pharmaceuticals Business Overview
  • Table 83. Jazz Pharmaceuticals Restless Legs Syndrome Product
  • Table 84. Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 85. Jazz Pharmaceuticals Recent Developments
  • Table 86. Omeros Corporation Company Details
  • Table 87. Omeros Corporation Business Overview
  • Table 88. Omeros Corporation Restless Legs Syndrome Product
  • Table 89. Omeros Corporation Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 90. Omeros Corporation Recent Developments
  • Table 91. Manhattan Pharmaceuticals Company Details
  • Table 92. Manhattan Pharmaceuticals Business Overview
  • Table 93. Manhattan Pharmaceuticals Restless Legs Syndrome Product
  • Table 94. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 95. Manhattan Pharmaceuticals Recent Developments
  • Table 96. Boehringer Ingelheim GmbH Company Details
  • Table 97. Boehringer Ingelheim GmbH Business Overview
  • Table 98. Boehringer Ingelheim GmbH Restless Legs Syndrome Product
  • Table 99. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 100. Boehringer Ingelheim GmbH Recent Developments
  • Table 101. UCB SA Company Details
  • Table 102. UCB SA Business Overview
  • Table 103. UCB SA Restless Legs Syndrome Product
  • Table 104. UCB SA Revenue in Restless Legs Syndrome Business (2017-2022) & (US$ Million)
  • Table 105. UCB SA Recent Developments
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Restless Legs Syndrome Market Share by Type: 2021 VS 2028
  • Figure 2. Pharmacological Therapy Features
  • Figure 3. Non-Pharmacological Therapy Features
  • Figure 4. Global Restless Legs Syndrome Market Share by Application: 2021 VS 2028
  • Figure 5. Below 35 YearsOld Case Studies
  • Figure 6. 35-50 Years Old Case Studies
  • Figure 7. Above50 YearsOld Case Studies
  • Figure 8. Restless Legs Syndrome Report Years Considered
  • Figure 9. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Restless Legs Syndrome Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Restless Legs Syndrome Market Share by Region: 2021 VS 2028
  • Figure 12. Global Restless Legs Syndrome Market Share by Players in 2021
  • Figure 13. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2021
  • Figure 15. North America Restless Legs Syndrome Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Restless Legs Syndrome Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Restless Legs Syndrome Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Restless Legs Syndrome Market Size Share by Country (2017-2028)
  • Figure 19. United States Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Restless Legs Syndrome Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Restless Legs Syndrome Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Restless Legs Syndrome Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Restless Legs Syndrome Market Size Share by Country (2017-2028)
  • Figure 25. Germany Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Restless Legs Syndrome Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Restless Legs Syndrome Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Restless Legs Syndrome Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Restless Legs Syndrome Market Size Share by Region (2017-2028)
  • Figure 35. China Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Latin America Restless Legs Syndrome Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Restless Legs Syndrome Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Restless Legs Syndrome Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Restless Legs Syndrome Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Restless Legs Syndrome Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Restless Legs Syndrome Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Restless Legs Syndrome Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Restless Legs Syndrome Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Restless Legs Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 55. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 56. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 57. Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 58. Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 59. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 60. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 61. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 62. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2017-2022)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!